Your data on MRCVSonline
The nature of the services provided by Vision Media means that we might obtain certain information about you.
Please read our Data Protection and Privacy Policy for details.

In addition, (with your consent) some parts of our website may store a 'cookie' in your browser for the purposes of
functionality or performance monitoring.
Click here to manage your settings.
If you would like to forward this story on to a friend, simply fill in the form below and click send.

Your friend's email:
Your email:
Your name:
 
 
Send Cancel

Vaccine Alliance signs Ebola vaccine deal
If approved, the vaccine would become one of the world's first licensed Ebola vaccines.

Agreement to push Ebola vaccine towards approval

A $5 million agreement to support the provision of an Ebola vaccine has been signed by Gavi, the Vaccine Alliance and global healthcare leader Merck Sharp & Dohme Corp (MSD).

Announced yesterday (20 Jan) at the World Economic Forum in Davis, the agreement will help push the vaccine towards regulatory approval.

Under the Advance Purchase Commitment, Gavi has provided the funding towards the development of MSD's Ebloa Zaire vaccine on the understanding that it will be submitted for approval by the end of 2017.

If approved, the vaccine would become one of the world's first licensed Ebola vaccines and Gavi would be able to begin purchasing the vaccine to create a stockpile for future outbreaks.

“The suffering caused by the Ebola crisis was a wake-up call to many in the global health community,” said Gavi CEO Dr Seth Berkley.

“New threats require smart solutions and our innovative financing agreement with Merck will ensure that we are ahead of the curve for future Ebola outbreaks.” 

Dr Julie Gerberding, executive vice president, strategic communications, global public policy and population health for Merck, added: “We are very pleased to join with Gavi in announcing this Advance Purchase Commitment agreement to support the provision of MSD’s investigational monovalent Ebola Zaire vaccine - in case of a resurgence of the Ebola outbreak or a new outbreak.

“We applaud Gavi for this bold step to be a part of the solution to address a disease that has impacted so many lives.”

The Ebola epidemic in West Africa has claimed the lives of more than 11,300 people and infected more than 28,600.

On 14 January, WHO announced that no new cases of Ebola had been reported in the three worst affected countries in the preceding 42 days.

Just hours after the announcement, which included a warning that sporadic flare-ups could occur, a case of Ebola was reported in Sierra Leone. 

Become a member or log in to add this story to your CPD history

Vets launch new podcast for pet owners

News Story 1
 Two independent vets have launched a podcast to help owners strengthen their bond with pets. Dr Maggie Roberts and Dr Vanessa Howie, who have worked in both veterinary practice and major charities, are keen to use their experience to enable people to give pets a better life.

The venture, called Vets Talking Pets, provides advice and information on a range of topics, including how to select a suitable pet, where to obtain them and how to get the best out of your vet. Maggie and Vanessa will also discuss sensitive subjects, including end-of-life care, raw food diets and the cost of veterinary care.

The podcast can be found on all the usual podcast sites, including Podbean, Apple, Amazon Music and YouTube. 

Click here for more...
News Shorts
RCVS Regional Question Time heads to Edinburgh

The RCVS is to bring its Regional Question Time (RQT) to Edinburgh for 2026.

The event will take place at Novotel Edinburgh Park in Edinburgh on Wednesday, 20 May 2026.

It will begin with supper and drinks at 6.30pm, with an evening programme from 7.30pm. This will start with an update on RCVS' activities, followed by questions and answers with representatives.

RCVS is encouraging an 'open dialogue', in which queries can be raised in a friendly, informal environment.

While discussions are expected to be audience-led, the RQT is expected address major issues including the VSA, the CMA's remedy package and the VN Vision project.

Tim Parkin, RCVS president, said: "It's an important time for the professions, and I'm looking forward to meeting colleagues in Scotland as we navigate this period of change together so we can come out stronger."

Tickets can be booked here.